Literature DB >> 19369433

Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HE-JF5/15F strain recovered from a fulminant hepatitis patient.

Toshinori Tanaka1, Masaharu Takahashi, Hideyuki Takahashi, Koji Ichiyama, Yu Hoshino, Shigeo Nagashima, Hitoshi Mizuo, Hiroaki Okamoto.   

Abstract

We developed an efficient cell culture system for genotype 4 hepatitis E virus using the HE-JF5/15F strain recovered from a fulminant hepatitis patient. The sixth-passage virus in the culture supernatant reached 1.5 x 10(8) copies/ml at 10 days postinoculation and possessed 10 nucleotide mutations with four amino acid changes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19369433      PMCID: PMC2691090          DOI: 10.1128/JCM.00629-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  40 in total

Review 1.  A review of hepatitis E virus.

Authors:  J L Smith
Journal:  J Food Prot       Date:  2001-04       Impact factor: 2.077

2.  The complete sequence of hepatitis E virus genotype 4 reveals an alternative strategy for translation of open reading frames 2 and 3.

Authors:  Y Wang; H Zhang; R Ling; H Li; T J Harrison
Journal:  J Gen Virol       Date:  2000-07       Impact factor: 3.891

3.  The 3' end of hepatitis E virus (HEV) genome binds specifically to the viral RNA-dependent RNA polymerase (RdRp).

Authors:  S Agrawal; D Gupta; S K Panda
Journal:  Virology       Date:  2001-03-30       Impact factor: 3.616

4.  Construction of an infectious cDNA clone of hepatitis E virus strain JE03-1760F that can propagate efficiently in cultured cells.

Authors:  Kentaro Yamada; Masaharu Takahashi; Yu Hoshino; Hideyuki Takahashi; Koji Ichiyama; Toshinori Tanaka; Hiroaki Okamoto
Journal:  J Gen Virol       Date:  2009-02       Impact factor: 3.891

Review 5.  Hepatitis E and pregnancy: understanding the pathogenesis.

Authors:  Udayakumar Navaneethan; Mayar Al Mohajer; Mohamed T Shata
Journal:  Liver Int       Date:  2008-07-25       Impact factor: 5.828

Review 6.  Hepatitis E: an emerging infection in developed countries.

Authors:  Harry R Dalton; Richard Bendall; Samreen Ijaz; Malcolm Banks
Journal:  Lancet Infect Dis       Date:  2008-11       Impact factor: 25.071

7.  Mutational events during the primary propagation and consecutive passages of hepatitis E virus strain JE03-1760F in cell culture.

Authors:  Felipe R Lorenzo; Toshinori Tanaka; Hideyuki Takahashi; Koji Ichiyama; Yu Hoshino; Kentaro Yamada; Jun Inoue; Masaharu Takahashi; Hiroaki Okamoto
Journal:  Virus Res       Date:  2008-07-26       Impact factor: 3.303

8.  Prolonged fecal shedding of hepatitis E virus (HEV) during sporadic acute hepatitis E: evaluation of infectivity of HEV in fecal specimens in a cell culture system.

Authors:  Masaharu Takahashi; Toshinori Tanaka; Masahiro Azuma; Eiji Kusano; Tatsuya Aikawa; Takao Shibayama; Yasuyuki Yazaki; Hitoshi Mizuo; Jun Inoue; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2007-08-29       Impact factor: 5.948

Review 9.  Genetic variability and evolution of hepatitis E virus.

Authors:  Hiroaki Okamoto
Journal:  Virus Res       Date:  2007-03-23       Impact factor: 3.303

10.  Production of monoclonal antibodies against hepatitis E virus capsid protein and evaluation of their neutralizing activity in a cell culture system.

Authors:  Masaharu Takahashi; Yu Hoshino; Toshinori Tanaka; Hideyuki Takahashi; Tsutomu Nishizawa; Hiroaki Okamoto
Journal:  Arch Virol       Date:  2008-02-12       Impact factor: 2.574

View more
  36 in total

1.  Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination.

Authors:  P Shukla; H T Nguyen; K Faulk; K Mather; U Torian; R E Engle; S U Emerson
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

2.  Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses.

Authors:  Nereida Jiménez de Oya; Estela Escribano-Romero; Ana-Belén Blázquez; María Lorenzo; Miguel A Martín-Acebes; Rafael Blasco; Juan-Carlos Saiz
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

Review 3.  Adaptive Immune Responses in Hepatitis A Virus and Hepatitis E Virus Infections.

Authors:  Christopher M Walker
Journal:  Cold Spring Harb Perspect Med       Date:  2019-09-03       Impact factor: 6.915

Review 4.  Hepatitis E virus: advances and challenges.

Authors:  Ila Nimgaonkar; Qiang Ding; Robert E Schwartz; Alexander Ploss
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-11-22       Impact factor: 46.802

Review 5.  Stem Cell-Derived Culture Models of Hepatitis E Virus Infection.

Authors:  Viet Loan Dao Thi; Xianfang Wu; Charles M Rice
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

6.  New Methods in Tissue Engineering: Improved Models for Viral Infection.

Authors:  Vyas Ramanan; Margaret A Scull; Timothy P Sheahan; Charles M Rice; Sangeeta N Bhatia
Journal:  Annu Rev Virol       Date:  2014-11       Impact factor: 10.431

7.  A naturally occurring human/hepatitis E recombinant virus predominates in serum but not in faeces of a chronic hepatitis E patient and has a growth advantage in cell culture.

Authors:  H T Nguyen; U Torian; K Faulk; K Mather; R E Engle; E Thompson; H L Bonkovsky; S U Emerson
Journal:  J Gen Virol       Date:  2011-11-23       Impact factor: 3.891

8.  Characterization of the Quasi-Enveloped Hepatitis E Virus Particles Released by the Cellular Exosomal Pathway.

Authors:  Shigeo Nagashima; Masaharu Takahashi; Tominari Kobayashi; Tsutomu Nishizawa; Takashi Nishiyama; Putu Prathiwi Primadharsini; Hiroaki Okamoto
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

Review 9.  Autochthonous hepatitis e virus infections: a new transfusion-associated risk?

Authors:  Jens Dreier; David Juhl
Journal:  Transfus Med Hemother       Date:  2013-12-30       Impact factor: 3.747

10.  Hepatitis E virus genotype 1 infection of swine kidney cells in vitro is inhibited at multiple levels.

Authors:  H T Nguyen; P Shukla; U Torian; K Faulk; S U Emerson
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.